Oscar Health, Inc. (OSCR) stock has dropped significantly, but is expected to perform well

From Nasdaq: 2025-03-21 16:43:00

Oscar Health, Inc. (OSCR) has been a top search on Zacks.com. Shares have dropped by -19.6% in the past month, while the Zacks S&P 500 composite fell by -7.5%. Analysts project earnings of $0.83 per share for the current quarter, a +33.9% change year-over-year.

Earnings estimate revisions play a crucial role in stock performance. Analysts’ revisions impact a stock’s fair value. Oscar Health is expected to see a +6.5% change in earnings for the next fiscal year. The Zacks Rank #3 (Hold) indicates a positive outlook for the stock.

Revenue growth is essential for a company’s financial health. Oscar Health has estimates of $2.8 billion for the current quarter, reflecting a +30.8% change year-over-year. The company reported revenues of $2.39 billion in the last quarter, with a surprise of -2.79% compared to estimates.

Valuation metrics show Oscar Health is trading at a discount compared to its peers. The Zacks Value Style Score rates it as A, indicating it is undervalued. With a Zacks Rank #3, the stock may perform in line with the market in the near term.



Read more at Nasdaq: Is Trending Stock Oscar Health, Inc. (OSCR) a Buy Now?